Author

Nuria Muelas Gómez

Observed names: Muelas Gómez, Nuria, Nuria Muelas Gomez

Institution: Hospital Universitari i Politècnic La Fe

Observed institutions: Hospital Universitari i Politècnic La Fe, Newcastle University

OpenAlex ID: A5102588257

Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

2024 · Eugenio Mercuri, Juan J Vilchez, et al. · The Lancet Neurology · 137

PCR230 Patient-Reported Outcomes From a Phase 3 Study of Givinostat in Patients With Duchenne Muscular Dystrophy

2025 · Laura McAdam, Federica Alessi, et al. · Value in Health · 2

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 48-Week Study of the Efficacy and Safety of Losmapimod in Subjects with FSHD: ReDUX4 (S23.007)

2022 · Rabi Tawil, Jeffrey Statland, et al. · Neurology · 1

Reachable Workspace to Evaluate Efficacy of Losmapimod in Subjects with FSHD in Two Phase 2 Studies (P4-13.008)

2022 · Michelle Mellion, Jay Han, et al. · Neurology

Whole Body MRI Quantitative muscle analysis to evaluate Efficacy of Losmapimod in a Phase 2 Placebo-Controlled Study in Subjects with FSHD (ReDUX4) (S23.009)

2022 · Michelle Mellion, Rabi Tawil, et al. · Neurology

Estudio de las miopatias distales, en particular de una forma endemica de la región de la Safor

2010 · Nuria Muelas Gómez · TDX (Tesis Doctorals en Xarxa)

Works count: 7

Citation count: 140

H-index: 2

I10-index: 1